ESMO肿瘤学真实世界证据报告规范(ESMO-GROW清单)解读  

Interpretation of ESMO guidelines for reporting real-world evidence in oncology(ESMO-GROW checklist)

作　　者：陈容 罗玲[1] 张运芝[1] 刘真 刘安林 张译文 CHEN Rong;LUO Ling;ZHANG Yunzhi;LIU Zhen;LIU Anlin;ZHANG Yiwen(Department of Infectious Diseases,the Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,P.R.China)

机构地区：[1]重庆医科大学附属第二医院感染病科,重庆400010

出　　处：《中国循证医学杂志》2025年第1期102-110,共9页Chinese Journal of Evidence-based Medicine

摘　　要：为促进肿瘤学真实世界证据研究的质量和透明度,欧洲肿瘤内科学会(ESMO)开发了首个针对肿瘤学真实世界证据研究的具体报告规范:ESMO guidance for reporting oncology real-world evidence(ESMOGROW)。为方便读者更好的对报告规范的理解与应用,本文对ESMO-GROW清单的制订过程和主要内容进行介绍和解读。To enhance the quality and transparency of oncology real-world evidence studies,the European Society for Medical Oncology(ESMO)has developed the first specific reporting guidelines for oncology RWE studies in peerreviewed journals"the ESMO Guidance for Reporting Oncology Real-World Evidence(GROW)".To facilitate readers understanding and application of these reporting standards,this article introduces and interprets the development process and main contents of the ESMO-GROW checklist.

关 键 词：真实世界数据 真实世界证据 肿瘤学研究 报告规范 解读 

分 类 号：R73[医药卫生—肿瘤]